share_log

益方生物(688382.SH):2023年净利润-2.84亿元

Yifang Biotech (688382.SH): 2023 net profit - $284 million

Gelonghui Finance ·  Apr 25 08:04

On April 25, Ge Longhui (688382.SH) released its 2023 annual report. During the reporting period, the company made every effort to promote clinical research and cooperative development of major products and made important progress. In 2023, it achieved operating income of 186 million yuan, net profit attributable to shareholders of listed companies - 284 million yuan, a year-on-year loss decrease of 41.26%. The loss margin was narrower compared to the same period last year, mainly due to the increase in the company's 2023 technical licensing and technical cooperation revenue.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment